Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

Clinical trial NCT05609695 · UNKNOWN

Trial details

NCT number: NCT05609695
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Study type: OBSERVATIONAL

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma

Start date: 2023-03-01
Primary completion: 2025-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.